Tamir Biotechnology Inc. (ACEL1)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Employees:
12625 HIGH BLUFF DRIVE, SUITE 213, SAN DIEGO, CA 92130
(732) 823-1003

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 2.366 Million Shares Outstanding47.32 Million Avg 30-day Volume 19.791 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0.05
Price to Revenue7.688 Debt to Equity-0.5075 EBITDA4.495 Million
Price to Book Value0.0 Operating Margin-3.1803999999999997 Enterprise Value7.088 Million
Current Ratio0.003 EPS Growth-0.875 Quick Ratio0.001
1 Yr BETA 0.0 52-week High/Low 0.0 / Profit Margin-43.9318
Operating Cash Flow Growth55.6546 Altman Z-Score-4882.3967 Free Cash Flow to Firm -1.329 Million
View SEC Filings from ACEL1 instead.

View recent insider trading info

Funds Holding ACEL1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ACEL1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SULLEY JAMIE MARIE PRESIDENT

  • Officer
  • Director
16,702,667 2013-02-05 0

BARSA JOANNE MARIE CHIEF FINANCIAL OFFICER

  • Officer
0 2013-02-05 0

OSTRONIC FRANCIS PATRICK

  • Director
0 2013-02-05 0

EUROPA INTERNATIONAL INC

KNOLL CAPITAL MANAGEMENT, LP

KNOLL FRED

  • 10% Owner
80,493,064 2012-12-14 0

WEISS PAUL M

  • Director
0 2012-07-23 0

KENYON LAWRENCE A PRESIDENT, CEO AND CFO

  • Officer
0 2012-07-23 0

BRANCACCIO JOHN P

  • Director
0 2012-07-23 0

SIDRANSKY DAVID

  • Director
0 2012-07-23 0

CONKLIN DONALD R

  • Director
0 2009-10-21 0

CARTER STEPHEN

  • Director
0 2009-10-21 0

MUNIZ CHARLES PRESIDENT, CEO AND CFO

  • Officer
  • Director
0 2009-10-19 0

LOUGHLIN JAMES J

  • Director
0 2008-12-31 0

KNOLL CAPITAL MANAGEMENT, LP

KNOLL FRED

  • 10% Owner
0 2007-08-31 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments